EUVIMED · CrossrefZeitschrift
Neuro-Oncology Advances
ISSN 2632-2498 · Oxford University Press (OUP)
Neueste Artikel
Distinct Molecular and Survival Manifestations in IDH-wildtype Glioblastomas without Contrast Enhancement: Interrelationship with Molecular Glioblastomas
Machine learning based quantification of T cell and myeloid cell distribution in the tumor microenvironment following adoptive T cell transfer in a preclinical glioma model
The role of extent of resection in gliosarcoma compared to glioblastoma–a volumetric matched-cohort assessment of residual contrast-enhancing tumor
Laser thermal ablation with a non-cooled laser fiber-a phase 1 clinical trial in glioblastoma and astrocytoma grade 4
Tracer-Specific Hemispheric Metabolic Reorganization in IDH-Wildtype Glioblastoma: A Longitudinal FDG and FDOPA PET/MR Study
Resting-state Compensatory Remapping in Patients with Brain Tumour Before and After Surgery
Plasma Cell-Free DNA-Based Next-Generation Sequencing for Molecular Profiling of Diffuse Gliomas
Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity
Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature review
The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort
Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets
A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status
The immune landscape of cerebrospinal fluid across brain malignancies
Intelligent histology for tumor neurosurgery
Hemizygous deletion of CDKN2A/B in IDH -mutated glioma: Prognostic impact when adjusting for clinical factors
Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers
Spherical radiomics for radiogenomic assessment of glioblastoma heterogeneity
Long-term outcomes and late complications of intracranial germinoma: Implications for follow-up policy
Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives
Postsurgical detection of glioma recurrence using MRI radiomics
Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials
Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series
Mapping intratumoral heterogeneity in adolescent CNS tumors using simultaneous amide proton transfer-weighted signal and 18F-choline PET: A feasibility study
Differentiating true progression from pseudoprogression in glioblastomas: Dynamic contrast-enhanced MRI habitat analysis with parsimonious pharmacokinetic model
Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment
Bromodomain and extra-terminal motif (BET) inhibition induces coordinated repression of the stem cell-related HOX signature in glioblastoma uncovering an epigenetic vulnerability
Sarcomatous transformation of an IDH-mutant oligodendroglioma matching to methylation class oligosarcoma despite vorasidenib use, a case report
Performance of intraoperative artificial intelligence-assisted label-free stimulated Raman histology in recurrent brain tumors
Immunologic specificity in glioblastoma: Antigen discovery and translational implications
EUVIMED